The DayOne Accelerator has helped launch more than 60 innovative healthtech ventures since we started operating in 2018. You can find details of all our active alumni companies below.
Latest update: 09/09/2025
Portfolio
In the spotlight
Oncoustics
Oncoustics applies AI to raw sound signals on low-cost ultrasound devices turning these into powerful virtual biopsy tools that will democratize diagnostics.
FindMeCure / Trialhub
TrialHub: Insights that turn trials into treatments.
Theremia
Theremia is an AI-driven platform that optimizes drug development by ensuring pharmaceutical companies create the right drug for the right population subgroups.
Risklick
Revolutionizing clinical trial protocol with first-in-class AI software.
Senseera Health
Senseera’s goal is to transform precision medicine for every patient and pioneer liver diagnostics through groundbreaking chromatin epigenomics.
Portfolio
Company
Therapeutic areas
Country
Funding Stage
Development stage
Risklick
Therapeutic area: z-Other
Country: Switzerland
Funding Stage: Serie A
Development stage: Commercial launch
AI-powered software that designs and optimizes clinical trial protocols to shorten development timelines.
Visit website
z-Other
Switzerland
Serie A
Commercial launch
Senseera Health
Therapeutic area: Hepatology, Immunology, Oncology
Country: Israel
Funding Stage: Serie A
Development stage: Preclinical research & prototyping
Next-generation chromatin liquid biopsy platform for non-invasive disease detection, monitoring and drug development.
Visit website
Hepatology, Immunology, Oncology
Israel
Serie A
Preclinical research & prototyping
Stitch Health
Therapeutic area: z-Other
Country: United Kingdom
Funding Stage: Seed
Development stage: Commercial launch
Patient engagement platform that reduces no-shows and boosts clinical trial enrollment.
Visit website
z-Other
United Kingdom
Seed
Commercial launch
Theremia
Therapeutic area: Neurology
Country: France
Funding Stage: Seed
Development stage: Preclinical research & prototyping
AI-powered precision medicine platform optimizing CNS drug efficacy and safety across patient subgroups.
Visit website
Neurology
France
Seed
Preclinical research & prototyping
TOM Medications
Therapeutic area: Chronic diseases
Country: Switzerland
Funding Stage: Seed
Development stage: Commercial launch
Anonymous medication reminder app helping chronic patients manage therapies and adherence.
Visit website
Chronic diseases
Switzerland
Seed
Commercial launch
Virtuosis AI
Therapeutic area: Brain Health, Cardiovascular diseases, Chronic diseases, Neurology, Preventive Health
Country: Switzerland
Funding Stage:
Development stage: Commercial launch
AI models analyzing vocal biomarkers for NCS, cardiometabolic and respiratory disorders.
Visit website
Brain Health, Cardiovascular diseases, Chronic diseases, Neurology, Preventive Health
Switzerland
Commercial launch
Veil.AI
Therapeutic area: z-Other
Country: Finland
Funding Stage: Serie A
Development stage: Regulatory approval & launch prep
Next-generation health data anonymization and synthetic data solutions for privacy-safe AI.
Visit website
z-Other
Finland
Serie A
Regulatory approval & launch prep
Wemedoo
Therapeutic area: Oncology, Ophtalmology, z-Other
Country: Switzerland
Funding Stage: Serie A
Development stage: Commercial launch
Unified clinical trial software and services turning fragmented clinical data into real-time insights.
Visit website
Oncology, Ophtalmology, z-Other
Switzerland
Serie A
Commercial launch
Zoundream
Therapeutic area: Pediatrics
Country: Switzerland
Funding Stage: Serie A
Development stage: Commercial launch
AI-based cry analysis that translates baby sounds and flags early infant health risks.
Visit website
Pediatrics
Switzerland
Serie A
Commercial launch
ZuriEV
Therapeutic area: Oncology
Country: Switzerland
Funding Stage: Pre seed
Development stage: Design & development
Blood-based liquid biopsy test enabling earlier, non-invasive brain cancer diagnosis.
Visit website
Oncology
Switzerland
Pre seed
Design & development
